The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Daly, R. C.
* Articles by Schmidt, P. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Daly, R. C.
* Articles by Schmidt, P. J.
Related Collections
* Neuroendocrinology
* Depression
Am J Psychiatry 160:1842-1846, October 2003
© 2003 American Psychiatric Association


Article

Concordant Restoration of Ovarian Function and Mood in Perimenopausal Depression

Robert C. Daly, M.D., M.P.H., Merry A. Danaceau, R.N., David R. Rubinow, M.D., and Peter J. Schmidt, M.D.

OBJECTIVE: Despite reports of estradiol’s therapeutic efficacy in perimenopausal depression, the relationship between ovarian function and mood in perimenopausal depression remains unclear. The purpose of this study was to examine changes in mood and pituitary-ovarian axis function in women exhibiting perimenopausal depression. METHOD: Depression ratings (from the Center for Epidemiologic Studies—Depression Scale [CES-D Scale]) and follicle-stimulating hormone (FSH) plasma levels of depressed perimenopausal women (N=110) attending a menopause clinic were obtained at baseline and after a 6-week screening period. RESULTS: Eighteen women experienced an improvement in depression (50% decline in CES-D Scale scores) at week 6, which was associated with a significant decrease in FSH plasma levels (baseline: mean=73.3 IU/liter [SD=42.0]; week 6: mean=42.2 IU/liter [SD=28.6]). Similarly, those subjects experiencing a 50% drop in FSH plasma levels had significant decreases in CES-D Scale scores (baseline: mean=23.3 [SD=6.8]; week 6: mean=18.1 [SD=10.9]). However, between women with CES-D Scale scores >=15 and those with CES-D Scale scores <15, no significant differences in FSH levels were observed either at baseline (mean=65.5 IU/liter [SD=35.7] and 60.9 IU/liter [SD=34.9], respectively) or at week 6 (mean=56.2 IU/liter [SD=36.6] and 51.5 IU/liter [SD=34.2]). CONCLUSIONS: Mood variability in women with perimenopausal depression may reflect episodic alterations in ovarian function that are best detected by longitudinal study designs.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
P. J. SCHMIDT
Depression, the Perimenopause, and Estrogen Therapy
Ann. N.Y. Acad. Sci., June 1, 2005; 1052(1): 27 - 40.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Perimenopausal Fluctuations in Mood and Hormones
Journal Watch Psychiatry, February 11, 2004; 2004(211): 11 - 11.
[Full Text]


Home page
JWatch Women's HealthHome page
Perimenopausal Fluctuations in Mood and Hormones
Journal Watch Women's Health, January 14, 2004; 2004(114): 7 - 7.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org